| Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route S Patel, S Chavhan, H Soni, AK Babbar, R Mathur, AK Mishra, K Sawant Journal of drug targeting 19 (6), 468-474, 2011 | 189 | 2011 |
| Bactericidal and sterilizing activity of a novel regimen with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide in a murine model of tuberculosis SY Li, R Tasneen, S Tyagi, H Soni, PJ Converse, K Mdluli, ... Antimicrobial agents and chemotherapy 61 (9), 10.1128/aac. 00913-17, 2017 | 81 | 2017 |
| Pharmacodynamic correlates of linezolid activity and toxicity in murine models of tuberculosis KM Bigelow, AN Deitchman, SY Li, K Barnes-Boyle, S Tyagi, H Soni, ... The Journal of infectious diseases 223 (11), 1855-1864, 2021 | 22 | 2021 |
| Mechanistic modeling of Mycobacterium tuberculosis infection in murine models for drug and vaccine efficacy studies N Zhang, N Strydom, S Tyagi, H Soni, R Tasneen, EL Nuermberger, ... Antimicrobial agents and chemotherapy 64 (3), 10.1128/aac. 01727-19, 2020 | 17 | 2020 |
| A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis S Leung-Theung-Long, CA Coupet, M Gouanvic, D Schmitt, A Ray, ... PLoS One 13 (5), e0196815, 2018 | 16 | 2018 |
| GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment EL Nuermberger, MS Martínez-Martínez, O Sanz, B Urones, J Esquivias, ... Antimicrobial agents and chemotherapy 66 (6), e00132-22, 2022 | 15 | 2022 |
| Investigation on resealed erythrocytes as carriers for 5-fluorouracil KK Sawant, HN Soni, RSR Murthy INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES 63 (2), 105-109, 2001 | 14 | 2001 |
| Formulation evaluation and in vitro and in vivo studies of PLA based vaccine for tuberculosis H Soni Vadodara, 2015 | 1 | 2015 |
| Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis SY Li, S Tyagi, H Soni, F Betoudji, PJ Converse, K Mdluli, AM Upton, ... Antimicrobial Agents and Chemotherapy, e01562-23, 2024 | | 2024 |
| Direct inhibitors of InhA with efficacy similar or superior to isoniazid in novel drug regimens for tuberculosis L Encinas, SY Li, J Rullas-Trincado, R Tasneen, S TYAGI, H Soni, ... bioRxiv, 2024.03. 08.584126, 2024 | | 2024 |
| APPLICATION OF MUCUS PENETRATING NANOPARTICLES IN MUCOSAL VACCINATION FOR TUBERCULOSIS: PROPHYLACTIC AND THERAPEUTIC VACCINE EFFICACY IN A MURINE MODEL HN Soni, H Patel, K Sawant, L Ensign, J Hanes, E Nuermberger | | |
